- Home
- BMEA vs UBCP Comparison
BMEA vs UBCP Comparison
Compare BMEA & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- UBCP
- Stock Information
- Founded
- BMEA 2017
- UBCP 1902
- Country
- BMEA United States
- UBCP United States
- Employees
- BMEA N/A
- UBCP N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- UBCP Major Banks
- Sector
- BMEA Health Care
- UBCP Finance
- Exchange
- BMEA Nasdaq
- UBCP Nasdaq
- Market Cap
- BMEA 65.8M
- UBCP 76.2M
- IPO Year
- BMEA 2021
- UBCP N/A
- Fundamental
- Price
- BMEA $1.81
- UBCP $13.94
- Analyst Decision
- BMEA Strong Buy
- UBCP
- Analyst Count
- BMEA 10
- UBCP 0
- Target Price
- BMEA $22.30
- UBCP N/A
- AVG Volume (30 Days)
- BMEA 5.2M
- UBCP 4.0K
- Earning Date
- BMEA 07-30-2025
- UBCP 08-06-2025
- Dividend Yield
- BMEA N/A
- UBCP 6.43%
- EPS Growth
- BMEA N/A
- UBCP N/A
- EPS
- BMEA N/A
- UBCP 1.24
- Revenue
- BMEA N/A
- UBCP $29,412,000.00
- Revenue This Year
- BMEA N/A
- UBCP N/A
- Revenue Next Year
- BMEA N/A
- UBCP $5.59
- P/E Ratio
- BMEA N/A
- UBCP $11.48
- Revenue Growth
- BMEA N/A
- UBCP N/A
- 52 Week Low
- BMEA $1.29
- UBCP $11.40
- 52 Week High
- BMEA $13.07
- UBCP $14.78
- Technical
- Relative Strength Index (RSI)
- BMEA 44.35
- UBCP 55.74
- Support Level
- BMEA $2.24
- UBCP $13.32
- Resistance Level
- BMEA $3.08
- UBCP $13.61
- Average True Range (ATR)
- BMEA 0.40
- UBCP 0.20
- MACD
- BMEA -0.03
- UBCP -0.02
- Stochastic Oscillator
- BMEA 25.07
- UBCP 70.51
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.